Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sehested

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Cancer Communications|January 1, 1990
Concerning antisense inhibition of the multiple drug resistance geneJ W Jaroszewski, O Kaplan, J L Syi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 14, 2001
Urokinase plasminogen activator is localized in stromal cells in ductal breast cancerB S Nielsen, M Sehested, S Duun, et al.
The Journal of Biological Chemistry|December 5, 1998
Essential mitotic functions of DNA topoisomerase IIalpha are not adopted by topoisomerase IIbeta in human H69 cellsP Grue, A Grässer, M Sehested, et al.
British Journal of Cancer|December 1, 1989
In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL)P B Jensen, L Vindeløv, H Roed, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 1, 1993
Abdominal ultrasound combined with histological and cytological fine needle biopsy of suspected ovarian tumorsT Larsen, S T Torp-Pedersen, M Ottesen, et al.
Cancer Research|June 30, 2001
DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biologyC Lukas, J Bartkova, L Latella, et al.
Biochemical Pharmacology|June 1, 1994
Antagonistic effect of aclarubicin on camptothecin induced cytotoxicity: role of topoisomerase IB S Sørensen, P B Jensen, M Sehested, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivityP B Jensen, H Roed, M Sehested, et al.
Biochemical Pharmacology|May 25, 1993
Different modes of anthracycline interaction with topoisomerase II. Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistanceP B Jensen, B S Sørensen, M Sehested, et al.
Brain Pathology (Zurich, Switzerland)|November 28, 2020
Distinct circular RNA expression profiles in pediatric ependymomasUlvi Ahmadov, Meile M Bendikas, Karoline K Ebbesen, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Cancer Communications|January 1, 1990
Concerning antisense inhibition of the multiple drug resistance geneJ W Jaroszewski, O Kaplan, J L Syi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 14, 2001
Urokinase plasminogen activator is localized in stromal cells in ductal breast cancerB S Nielsen, M Sehested, S Duun, et al.
The Journal of Biological Chemistry|December 5, 1998
Essential mitotic functions of DNA topoisomerase IIalpha are not adopted by topoisomerase IIbeta in human H69 cellsP Grue, A Grässer, M Sehested, et al.
British Journal of Cancer|December 1, 1989
In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL)P B Jensen, L Vindeløv, H Roed, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 1, 1993
Abdominal ultrasound combined with histological and cytological fine needle biopsy of suspected ovarian tumorsT Larsen, S T Torp-Pedersen, M Ottesen, et al.
Cancer Research|June 30, 2001
DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biologyC Lukas, J Bartkova, L Latella, et al.
Biochemical Pharmacology|June 1, 1994
Antagonistic effect of aclarubicin on camptothecin induced cytotoxicity: role of topoisomerase IB S Sørensen, P B Jensen, M Sehested, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivityP B Jensen, H Roed, M Sehested, et al.
Biochemical Pharmacology|May 25, 1993
Different modes of anthracycline interaction with topoisomerase II. Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistanceP B Jensen, B S Sørensen, M Sehested, et al.
Brain Pathology (Zurich, Switzerland)|November 28, 2020
Distinct circular RNA expression profiles in pediatric ependymomasUlvi Ahmadov, Meile M Bendikas, Karoline K Ebbesen, et al.
Pageof 10